MODIFICATION OF ESCALATED BEACOPP WITH DACARBAZINE SUBSTITUTION REDUCES TOXICITY WHILE MAINTAINING EFFICACY FOR THE TREATMENT OF ADVANCED STAGE HODGKIN LYMPHOMA

Autor:	K. Sturgess, M. Furtado, G. Stafford, S. G. Jones, Tobias Menne, Andrew McMillan, Kaljit Bhuller, Thomas Creasey, Graham P. Collins, Deirdre O'Mahony, Anna Santarsieri, Sateesh K Nagumantry, George A Follows, Stephen Booth, John F. Rudge, Nicolas Martinez-Calle, Benjamin J Uttenthal, A. Sternberg, Pauline Brice, Nimish Shah, S. Behan, Kate Cwynarski, Pamela McKay, Wendy Osborne, S. Iyenga, Kirit M. Ardeshna
Rok vydání:	2021
Předmět:	Oncology BEACOPP Cancer Research medicine.medical_specialty business.industry Dacarbazine medicine.medical_treatment Substitution (logic) Advanced stage Hematology General Medicine Internal medicine Toxicity medicine Hodgkin lymphoma business medicine.drug
Zdroj:	Hematological Oncology. 39
ISSN:	1099-1069 0278-0232
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d79f006a04cad37bad4f04e267e56ca6 https://doi.org/10.1002/hon.109_2880 Zobrazit plný text záznamu Plný text